Pain-free method of monitoring drug levels in transplant patients

The U.S. Patent and Trademark Office is reviewing a University of Rhode Island pharmacy professor's proposal to use saliva as a non-invasive way to monitor concentrations of anti-rejection drugs in patients that undergo transplants.

If you want to include this story in your blog, copy and paste this formatted text: